Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.116 EUR | -2.45% |
|
-5.74% | -68.61% |
28/06 | AB Science: negative CHMP opinion for masitinib in ALS | CF |
03/06 | AB Science: share price falls on resumption of trading | CF |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-68.61% | 70.71M | |
+7.39% | 72.09B | |
+15.93% | 9.05B | |
-22.81% | 4.4B | |
+17.59% | 4.39B | |
+25.93% | 3.94B | |
+4.64% | 2.1B | |
+9.09% | 1.97B | |
-36.86% | 1.87B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- AB Stock
- News AB Science
- AB Science's Reconsideration Request for ALS Treatment Granted Eligibility in Canada